Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan as preischemic myocardial conditioning in pediatric cardiac surgery
2012-005310-19Phase 3Active
- Sponsor
- Fundación para la Investigación Biosanitaria de Andalucía Oriental
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levosimendan in Cardiovascular Malformation (CVM) and Acute Heart Failure (AHF) (2 arms), sponsored by Fundación para la Investigación Biosanitaria de Andalucía Oriental. Primary endpoint: Hemodynamic. Started Feb 2013; status: active.
02
Drugs
levosimendan
03
Conditions
Cardiovascular Malformation (CVM)Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2012-005310-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005310-19.